What to know about the new Alzheimer's drug Leqembi - The So

The Food and Drug Administration has granted full approval to Leqembi for patients in the early stages of Alzheimer’s disease. Washington University School of Medicine's Barbara Joy Snider, MD, PhD, answers questions about the drug.

Related Keywords

, Memory Diagnostic Center , Drug Administration , Washington University Knight , Washington University , National Institutes Of Health , Washington University School Of Medicine Charles , School Of Medicine , Joanne Knight Alzheimer Disease Research Center , Alzheimer Network , Washington University School , Joy Snider , Dominantly Inherited Alzheimer Network , National Institutes , Although Leqembi ,